Kawakami Mark
- SEC CIK
- 0002030709
No open-market purchases or sales filed in the past year.
Current role at each company
- RKDA Arcadia Biosciences, Inc.Chief Financial Officeras of May 12, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kawakami Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Kawakami MarkChief Financial Officer | PPurchase | +700 | $2.49 | +$1.74K | +35.3%2.68K after | |
| Aug 20, 2024 (view filing) | Aug 1 | 19 daysLate | Kawakami MarkChief Financial Officer | PPurchase | +700 | $2.06 | +$1.44K | +54.6%1.98K after |